The new coronavirus detection kit developed by Zhongxiu Technology has successfully passed the performance verification of the German Paul Ehrlich Institute PEI (German: Paul-Ehrlich-Institut), which means that the new crown antigen detection kit of Zhongxiu Technology has passed the European gold content and recognition. The highest test, successful entry into the German market!
The German Paul-Ehrlich-Institut (PEI), also known as the German Federal Institute for Vaccines and Biomedicine, is affiliated to the Federal Ministry of Health (BMG). At the same time, it undertakes to provide scientific advice to different organizations, especially for the drafting and revision of relevant regulations in some EU countries, EU and international committees, and also provides professional opinions for the German government, local institutions and Congress, and provides Relevant information to patients and consumers.
Now that the delta virus strain is raging around the world, it has put forward higher requirements for the epidemic prevention work of various countries. In order to help the epidemic prevention and control work, the rapid screening kit for the new coronavirus has been used as an effective tool for epidemic prevention and control!
The new coronavirus rapid antigen detection reagent of Zhongxiu Technology adopts the lateral flow immunoassay method for the qualitative detection of the new coronavirus antigen in patients with suspected infection. The product is simple to sample, including various test samples such as oropharyngeal swabs, anterior nasal swabs, and saliva. It is easy to operate, and the test results can be obtained within 15 minutes. It is suitable for home and personal self-testing, as well as on-site testing in anti-epidemic work. with mass screening.
In addition, the rapid detection of new crown antibodies and the rapid detection of new crown neutralizing antibodies developed by Zhongxiu Technology provide a more comprehensive new crown solution for global epidemic prevention work, which can better meet the needs of global epidemic prevention.
Zhongxiu Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbiological series, biochemical series immune series and other reagents and supporting instruments.
Diversified R&D projects can meet the needs of cardiovascular, inflammatory, renal and hormonal disease detection and bacterial detection, covering various application environments such as hospitals at all levels, community outpatient clinics, health centers, and laboratories. The company has always adhered to the core concept of “fast and accurate, living up to life”, and is committed to providing excellent products and services to the society and contributing to the cause of human health.
Passing the German PEI performance verification is not only an affirmation of Zhongxiu Technology’s products, but also in the era of anti-epidemic, Zhongxiu Technology will continue to work hard and continue to contribute to the society!